Suppr超能文献

NOD 糖尿病的发病机制是由对胰岛素 B 链 9-23 表位的反应引发的,涉及功能表位扩展。

Pathogenesis of NOD diabetes is initiated by reactivity to the insulin B chain 9-23 epitope and involves functional epitope spreading.

机构信息

Department of Microbiology-Immunology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.

出版信息

J Autoimmun. 2012 Dec;39(4):347-53. doi: 10.1016/j.jaut.2012.04.005. Epub 2012 May 28.

Abstract

Type 1 diabetes (T1D) is mediated by destruction of pancreatic β-cells by CD4 and CD8 T cells specific for epitopes on numerous diabetogenic autoantigens resulting in loss of glucose homeostasis. Employing antigen-specific tolerance induced by i.v. administration of syngeneic splenocytes ECDI cross-linked to various diabetogenic antigens/epitopes (Ag-SP), we show that epitope spreading plays a functional role in the pathogenesis of T1D in NOD mice. Specifically, Ag-SP coupled with intact insulin, Ins B(9-23) or Ins B(15-23), but not GAD65(509-528), GAD65(524-543) or IGRP(206-214), protected 4-6 week old NOD mice from the eventual development of clinical disease; infiltration of immune cells to the pancreatic islets; and blocked the induction of DTH responses in a Treg-dependent, antigen-specific manner. However, tolerance induction in 19-21 week old NOD mice was effectively accomplished only by Ins-SP, suggesting Ins B(9-23) is a dominant initiating epitope, but autoimmune responses to insulin epitope(s) distinct from Ins B(9-23) emerge during disease progression.

摘要

1 型糖尿病(T1D)是由针对众多糖尿病自身抗原上表位的 CD4 和 CD8 T 细胞介导的,导致葡萄糖稳态丧失。我们通过静脉内给予同基因脾细胞 ECDI 交联到各种糖尿病自身抗原/表位(Ag-SP)来诱导抗原特异性耐受,结果表明,表位扩展在 NOD 小鼠 T1D 的发病机制中起着功能作用。具体而言,Ag-SP 与完整的胰岛素、Ins B(9-23)或 Ins B(15-23)结合,但不与 GAD65(509-528)、GAD65(524-543)或 IGRP(206-214)结合,可保护 4-6 周龄的 NOD 小鼠免受临床疾病的最终发展;免疫细胞浸润到胰岛;并以 Treg 依赖性、抗原特异性方式阻断 DTH 反应的诱导。然而,仅在 19-21 周龄的 NOD 小鼠中诱导耐受才能有效实现,这表明 Ins B(9-23)是一个主要的起始表位,但在疾病进展过程中会出现针对不同于 Ins B(9-23)的胰岛素表位的自身免疫反应。

相似文献

2
Genetic and therapeutic control of diabetogenic CD8+ T cells.致糖尿病性CD8 + T细胞的基因与治疗性控制
Novartis Found Symp. 2008;292:130-6; discussion 136-45, 202-3. doi: 10.1002/9780470697405.ch12.
6
Type 1 diabetes induction in humanized mice.人源化小鼠的 1 型糖尿病诱导。
Proc Natl Acad Sci U S A. 2017 Oct 10;114(41):10954-10959. doi: 10.1073/pnas.1710415114. Epub 2017 Sep 5.

引用本文的文献

1
Antigen-specific T cell responses in autoimmune diabetes.自身免疫性糖尿病中的抗原特异性 T 细胞应答。
Front Immunol. 2024 Aug 15;15:1440045. doi: 10.3389/fimmu.2024.1440045. eCollection 2024.
2
De novo identification of CD4 T cell epitopes.从头鉴定 CD4 T 细胞表位。
Nat Methods. 2024 May;21(5):846-856. doi: 10.1038/s41592-024-02255-0. Epub 2024 Apr 24.
4
Autoimmune diseases: targets, biology, and drug discovery.自身免疫性疾病:靶点、生物学和药物发现。
Acta Pharmacol Sin. 2024 Apr;45(4):674-685. doi: 10.1038/s41401-023-01207-2. Epub 2023 Dec 14.
5
Cell and biomaterial delivery strategies to induce immune tolerance.细胞和生物材料传递策略诱导免疫耐受。
Adv Drug Deliv Rev. 2023 Dec;203:115141. doi: 10.1016/j.addr.2023.115141. Epub 2023 Nov 18.
6
Vaccines for immune tolerance against autoimmune disease.针对自身免疫性疾病的免疫耐受疫苗。
Adv Drug Deliv Rev. 2023 Dec;203:115140. doi: 10.1016/j.addr.2023.115140. Epub 2023 Nov 18.
7

本文引用的文献

6
Prediction and pathogenesis in type 1 diabetes.1 型糖尿病的预测与发病机制。
Immunity. 2010 Apr 23;32(4):468-78. doi: 10.1016/j.immuni.2010.03.018.
7
Chromogranin A is an autoantigen in type 1 diabetes.嗜铬粒蛋白 A 是 1 型糖尿病的自身抗原。
Nat Immunol. 2010 Mar;11(3):225-31. doi: 10.1038/ni.1844. Epub 2010 Feb 7.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验